(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) dropped by a staggering 13.85% to €5.60 at 14:39 EST on Wednesday, after three successive sessions in a row of losses. CAC 40 is sliding 0.25% to €7,276.07, after two sequential sessions in a row of losses. This seems, up until now, a somewhat down trend trading session today.
ABL Diagnostics’s last close was €6.50, 59.58% below its 52-week high of €16.08.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.12%.
More news about ABL Diagnostics (ABLD.PA).
